scholarly journals Factors Related to Medication Adherence of Cognitively Impaired Patients in Community Pharmacies

2012 ◽  
Vol 03 (03) ◽  
pp. 368-380 ◽  
Author(s):  
Yoko Nanaumi ◽  
Mitsuko Onda ◽  
Yusuke Mukai ◽  
Rie Tanaka ◽  
Kenichi Tubota ◽  
...  
Keyword(s):  
Medication Adherence ◽  
Cognitively Impaired ◽  
Community Pharmacies

Effectiveness of a web-based medication adherence tool with patient centered communication: Results of a clustered randomized controlled trial (Preprint)

2019 ◽  
Author(s):  
Jan van Lieshout ◽  
Joyca Lacroix ◽  
Aart van Halteren ◽  
Martina Teichert
Keyword(s):  
Randomized Controlled Trial ◽  
Medication Adherence ◽  
Controlled Trial ◽  
Intervention Group ◽  
Control Group ◽  
Community Pharmacies ◽  
Web Based ◽  
Randomized Controlled ◽  
Tailored Interventions ◽  
Increased Risk

BACKGROUND Growing numbers of people use medication for chronic conditions; non-adherence is common, leading to poor disease control. A newly developed web-based tool to identify an increased risk for non-adherence with related potential individual barriers might facilitate tailored interventions and improve adherence. OBJECTIVE To assess the effectiveness of the newly developed tool to improve medication adherence. METHODS A cluster randomized controlled trial assessed the effectiveness of this adherence tool in patients initiating cardiovascular or oral blood glucose lowering medication. Participants were included in community pharmacies. They completed an online questionnaire comprising an assessments of their risk for medication non-adherence and subsequently of barriers to adherence. In pharmacies belonging to the intervention group, individual barriers displayed in a graphical profile on a tablet were discussed by pharmacists and patients at high non-adherence risk in face to face meetings and shared with their general practitioners and practice nurses. Tailored interventions were initiated by the healthcare providers. Barriers of control patients were not presented or discussed and these patients received usual care. The primary outcome was the difference in medication adherence at 8 months follow-up between patients with an increased non-adherence risk from intervention and control group, calculated from dispensing data. RESULTS Data from 492 participants in 15 community pharmacies were available for analyses (intervention 253, 7 pharmacies; control 239, 8 pharmacies). The intervention had no effect on medication adherence (-0.01; 95%CI -0.59 – 0.57; P= .96), neither in the post hoc per protocol analysis (0.19; 95%CI -0.50 – 0.89; P=.58). CONCLUSIONS This study showed no effectiveness of a risk stratification and tailored intervention addressing personal barriers for medication adherence. Various potential explanations for lack of effect were identified. These explanations relate for instance to high medication adherence in the control group, study power and fidelity. Process evaluation should elicit possible improvements and inform the redesign of intervention and implementation. CLINICALTRIAL The Netherlands National Trial Register: NTR5186. Date: May 18, 2015 (http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5186)

scholarly journals Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Clemence Perraudin ◽  
Jean-François Locca ◽  
Christophe Rossier ◽  
Olivier Bugnon ◽  
Marie-Paule Schneider
Keyword(s):  
Medication Adherence ◽  
Community Pharmacies ◽  
Chronic Patients

scholarly journals Impact of Pharmacists’ Interventions and Patients’ Decision on Health Outcomes in Terms of Medication Adherence and Quality Use of Medicines among Patients Attending Community Pharmacies: A Systematic Review

2021 ◽  
Vol 18 (9) ◽  
pp. 4392
Author(s):  
Kingston Rajiah ◽  
Shreeta Sivarasa ◽  
Mari Kannan Maharajan
Keyword(s):  
Medication Adherence ◽  
Health Outcomes ◽  
Systematic Reviews ◽  
Effective Interaction ◽  
Self Care ◽  
Community Pharmacists ◽  
Community Pharmacies ◽  
Quality Use Of Medicines ◽  
The Impact ◽  
Decision Choice

Community pharmacists are responsible for providing the appropriate information on the use of medications to patients, which may enhance their medication adherence. The extent of control that patients have on their health care preferences creates many challenges for community pharmacists. This study aimed to determine the impact of pharmacist interventions and patient decisions on health outcomes concerning medication adherence and the quality use of medicines among patients attending community pharmacies. Appropriate studies were identified in a systematic search using the databases of Medline, Scopus, Google Scholar, and PubMed. The search included literature published between 2004 and 2019. The database searches yielded 683 titles, of which 19 studies were included after the full-text analysis with a total of 9313 participants. Metaprop command in Stata software version 14 was used for the analysis. This study was undertaken based on the general principles of the Cochrane Handbook for Systematic Reviews of Interventions and subsequently reported according to the Preferred Reporting Items for Systematic Reviews (PRISMA) extension. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach was directly used to rate the quality of evidence (high, moderate, low, or very low). The results revealed the effective interaction between patients and community pharmacists, the importance of pharmacist intervention on medication adherence and quality use of medicine, and the role of community pharmacists in counselling patients. Decision/choice of patients in self-care and self-medication is a factor contributing to health outcomes. Effective interaction of community pharmacists with patients in terms of medication adherence and quality use of medicines provided a better health outcome among patients. The community pharmacists influenced the decision/choice of patients in self-care and self-medications.

scholarly journals Assessment of medication adherence and responsible use of isotretinoin and contraception through Belgian community pharmacies by using pharmacy refill data

2018 ◽  
Vol Volume 12 ◽  
pp. 153-161 ◽  
Author(s):  
Natacha Biset ◽  
Mélanie Lelubre ◽  
Christelle Senterre ◽  
Karim Amighi ◽  
Olivier Bugnon ◽  
...  
Keyword(s):  
Medication Adherence ◽  
Community Pharmacies ◽  
Pharmacy Refill

scholarly journals CRITICAL REVIEW OF THE DETERMINANTS OF MEDICATION ADHERENCE IN PATIENTS WITH DEMENTIA

2020 ◽  
pp. 1-9
Author(s):  
LLOYD RICHARDSON ◽  
HANA MORRISSEY ◽  
PATRICK BALL
Keyword(s):  
Medication Adherence ◽  
Critical Review ◽  
Meta Analysis ◽  
Cognitively Impaired ◽  
Summary Table ◽  
Conflicting Information ◽  
Causative Relationship ◽  
Relationship Of ◽  
The Impact

Objective: Medication adherence is a prominent issue in the general population; therefore, due to the nature of dementia, the risk of medication no adherence is even greater. Furthermore, there have been discrepancies regarding the impact of specific determinants on medication adherence as previous literature has cited conflicting information. This review aimed to identify the potential causative relationship of dementia that may result in medication non-adherence. Methods: A meta-analysis of (15 primary research papers) was conducted to identify and assess the specific themes and determinants related to non-adherence, and their impact on medication adherence in those who were cognitively impaired. Results: Four domains were established or developed upon review and risk of bias and risk of the summary table were created. A critical review undertaken to analyse various papers and their respective findings. Through the data analysis it was found that common themes could be established, such as Cognitive impairment, Disability, Mental illness and occasional forgetfulness to take their medication. The impact of each domain was expressed e. g. the predominant role of executive function and memory as well as non-adherence leading to delusional or suspicious thoughts. Conclusion: The findings align with current literature. The caregiver aspect needs to be addressed more thoroughly and more investigations are required such as identifying underlying factors that may potentially result in influence.

scholarly journals Psychosocial correlates of medication adherence among HIV-positive, cognitively impaired individuals

2016 ◽  
Vol 15 (4) ◽  
pp. 404-416
Author(s):  
Timothy J. Arentsen ◽  
Stella Panos ◽  
April D. Thames ◽  
J. Natalie Arbid ◽  
Steven A. Castellon ◽  
...  
Keyword(s):  
Medication Adherence ◽  
Hiv Positive ◽  
Cognitively Impaired ◽  
Psychosocial Correlates

Impact of Community Pharmacist Interventions With Managed Care to Improve Medication Adherence

2019 ◽  
pp. 089719001989650
Author(s):  
Christopher J. Daly ◽  
Kelly Verrall ◽  
David M. Jacobs
Keyword(s):  
Medication Adherence ◽  
Community Pharmacist ◽  
Angiotensin Receptor Blockers ◽  
Adverse Outcomes ◽  
Third Party ◽  
Future Research ◽  
Community Pharmacies ◽  
Improve Medication Adherence ◽  
Converting Enzyme Inhibitors ◽  
The Impact

Background: Nonadherence to medications is a concern due to adverse outcomes and higher costs of care. The Centers for Medicare and Medicaid Services has made adherence a key measurement for Star ratings. Objective: To evaluate the impact of a collaborative pilot program between a third-party payer, local pharmacy organization, and academic institution focusing on improving medication adherence with community pharmacies. Methods: Twenty-five community pharmacies implemented adherence-based interventions in patients ≥65 years old, who were Medicare Advantage Plan members, taking targeted medications (statins, oral diabetic medications, angiotensin-converting enzyme inhibitors [ACE-Is] and angiotensin receptor blockers [ARBs]). Outcome measures were (1) pharmacy intervention completion rate, (2) type of adherence interventions, (3) change in the proportion of days covered (PDC) following pharmacist intervention based on adherence group, and (4) nonadherence barriers. Results: A total of 1263 interventions met the eligibility criteria, and common interventions included explaining the benefit of the medication (n = 453, 35.9%) and provider follow-up (n = 109, 8.6%). Among nonadherent subjects who became adherent, the mean PDC increased by 14% (74%-88%, P < .0001), with a 12% decrease in mean PDC score in the nonadherent who remained nonadherent group (71%-58%, P < .0001). Common patient barriers for nonadherence were forgetfulness (n = 451, 35.7%) and denial (n = 84, 6.7%). System and therapeutic barriers included complexity (n = 155, 12.3%) and adverse side effects (n = 42, 3.3%). Conclusion: This collaborative effort successfully implemented a community pharmacist-led adherence intervention in 25 independent pharmacies. Our findings highlight increased interactions with patients and in some cases improved adherence measures. Future research must include implementation outcomes in order to effectively implement these interventions in the community pharmacy setting.

Sign in / Sign up

Export Citation Format

Share Document